• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND ENDURANT II EXTENSION STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND ENDURANT II EXTENSION STENT GRAFT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number ETTF2323C70E
Device Problem Folded (2630)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/14/2018
Event Type  malfunction  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
An endurant tube stent graft was implanted in the patient for the endovascular treatment of a 30mm saccular abdominal aortic aneurysm and penetrating atherosclerotic ulcer.It was reported, during the index procedure, that the physician decided to use an aortic extension graft tube only to exclude the aneurysm in the mid abdominal aorta.The graft was inserted into the patient via the right femoral artery using a cutdown approach and deployed at the level of the lowest accessory renal artery.The stent graft landed just above the aortic bifurcation.It was then reported that the physician re-captured the delivery system and removed it from the patient.Ballooning was performed using a reliant balloon and an angiogram was taken where no leaks were noted, and all vessels appeared to be intact, it was observed however, it did appear like the graft was not opposing the wall on the right side of the aorta.Further investigation showed that the stent graft appeared to be pushing up on itself along the posterior wall.The physician noted that the distal edge of the aneurysm was very close to the area with the stent graft pushing up on itself and the ct showed heavy plaque which might have caused the graft to catch on it.The graft was re-ballooned, and a tour guide sheath was used in an attempt to catch the stent graft and pull it back into its intended position.The physician commented that the patient had good blood flow throughout and the procedure was completed.Per the physician the cause of the event cannot be determined.No clinical sequalae were reported and the patient will be monitored.
 
Manufacturer Narrative
Film evaluation summary: from the films provided the exact cause of the mal-deployed distal stent and potential infolding could not be determined from the films provided.Pre-implant ct¿s revealed that the patient had a 26mm max diameter x 22mm length saccular aaa located ~55mm below the renal arteries.The infrarenal aorta was essentially straight.The distal aortic seal diameter ranged from 17 ¿ 18mm along a 3cm length and there was a significant area of calcification observed on the posterior aortic wall immediately below the aaa which reduced the flow lumen diameter to ~14 x 16mm.Two (2) still non-contrast films during implant revealed that the distal end of the stent graft (and associated graft marker bands) appeared to have been implanted mal-deployed and may have infolded; the distal marker on the patient¿s left side was 15 ¿ 20mm below/distal to the distal marker on the right side.Images during stent graft deployment and removal of the delivery system were not available, and post-ct¿s were also not provided to help assess the stent graft cross-section and lumen patency.It is possible that implanting the distal end of the stent graft within a location of notable calcification and resulting lumen narrowing, may have led to the observed mal-deployment and possible stent graft infolding.Since the films were non-contrast with no observed scale, no assessment of any endoleak, aneurysm exclusion, or stent graft patency could be performed, and no stent graft or vessel measurements could be performed.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Device evaluation summary: slight bending was evident to the tip.There was no evidence of scratches or damage caused by calcification observed on the tip.No abnormalities were noted retracting and advancing the graft cover and tip capture.There was no further damage noted to the delivery system.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDURANT II EXTENSION STENT GRAFT
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
091708096
MDR Report Key7327157
MDR Text Key102082357
Report Number2953200-2018-00349
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00613994991478
UDI-Public00613994991478
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 10/03/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/13/2019
Device Model NumberETTF2323C70E
Device Catalogue NumberETTF2323C70E
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/12/2018
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/14/2018
Initial Date FDA Received03/09/2018
Supplement Dates Manufacturer Received03/15/2018
06/21/2018
08/08/2018
Supplement Dates FDA Received04/11/2018
07/11/2018
10/03/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/13/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age80 YR
-
-